ICE-HBV member Thomas Tu (@thatliverguy) is a finalist for the Coles People's Choice Award at the 2024 Sydney Awards! 🌟👏
Support his vital work as a #hepatitisB scientist, advocate, and community member.
👉 Vote here: https://t.co/wz4ZUU4pjr
Your vote can make a difference! 🗳️
We are looking for two SRAs in Virology with focus on HIV or HBV. If you have experience in cell culture/mol. bio, and are passionate to develop therapies against infectious diseases, check out these job opportunities. Located in our beautiful SF/Mission Bay HQ. Links below 👇
Great gala by the @HepBFoundation to celebrate a year of progress against #HBV. Congratulations to honorees Prof. Stephan Urban, Ph.D., and Su Wang, M.D., M.P.H. (@Swang8)! Let's keep raising awareness and working to protect lives.
Check out recent research led by Vir scientists Michael A. Schmid and @FLempp on a unique monoclonal antibody (mAb) that aims to fight chronic hepatitis B and D infections (HBV/HDV) by reducing circulating HBsAg and viremia:
1/4
Vir is pleased to announce we have been awarded a @BARDA contract with an initial investment of approx. $55M, which also allows for potential total investment of up to $1B, to support pandemic preparedness for influenza/other infectious disease threats. https://t.co/gjgj0THDjh
We’re hiring a Scientist/Virologist to help develop novel medicines against #HBV and #HDV Please forward to potential candidates. #virology https://t.co/GhPmcCKb3z
Vir is excited for @EASLnews#ILC2022. We will join the Hepatitis Delta International Network meeting today, and present new #HBV data on June 25. We are taking a bold approach to developing new therapies intended to support millions of patients with significant unmet needs.
We are looking for an Associate Director level clinical immunologist to join our Biomarker group at VIR. Come join an incredible team working to bring new therapeutics to respiratory viral pathogens, including SARS-CoV-2 and Influenza. #hiring#immunology
https://t.co/h4QtQ2zX8C
📢 Job alert (please RT): my lab is looking for a PhD-level scientist to join us @czbiohub. We study virus-host interactions across different viral families using a combination of CRISPR/base editing screens, molecular virology and cell bio methods. https://t.co/mWr15CIntd
A paper in Nature shows that three C-type lectin receptors function as viral entry enhancing attachment receptors for SARS-CoV-2 and that the neutralizing properties of some antibodies are modulated by the expression of these lectins. https://t.co/lk4JZuqLkh
Science tells us that most Americans do not need a COVID-19 vaccine booster (1/3)
1. With time, vaccine-induced antibodies wane but the same happens with all vaccines and infections.